External Validation of START nomogram to predict 3-Month unfavorable outcome in Chinese acute stroke patients
External Validation of START nomogram to predict 3-Month unfavorable outcome in Chinese acute stroke patients
复制标题
START 列线图预测中国急性卒中患者 3 个月不良结果的外部验证
DOI:
10.1016/j.jstrokecerebrovasdis.2019.02.032
复制
发表时间:
2019
影响因子:
2.5
通讯作者:
Zou JianJun
中科院分区:
文献类型:
--
作者:
Song BaiLi;Chen XiangLiang;Tang Dan;Ibrahim Mako;Liu YuKai;Nyame Linda;Jiang Teng;Wang Wei;Li Xiang;Sun Chao;Zhao Zheng;Yang Jie;Zhou JunShan;Zou JianJun
BackgroundRecently, the NIHSS STroke Scale score, Age, pre-stroke mRS score, onset-to-treatment Time (START nomogram) predicts 3-month functional outcome after intravenous thrombolysis in ischemic stroke patients. However, this model has not yet been an external validation. We aim to validate the performance of START nomogram.MethodsData were derived from the stroke center of the Nanjing First Hospital (China). Patients who lacked the necessary data to calculate the nomogram and missed 3-month modified Ranking scale scores were excluded. Modified Rankin Scale score more than 2 at 3-month was assessed as an unfavorable outcome. We used areas under the receiver operator characteristic curves (AUC-ROC) to quantify the prognostic value. Calibration was assessed by calibration plots and Hosmer-Lemeshow (HL) goodness of fit test.ResultThe final cohort included 306 eligible patients. For 3-month unfavorable outcome, the AUC-ROC of the START nomogram was .766 (95%CI: .7013-.8304,P< .0001), suggesting good discrimination in the START nomogram. It also showed good calibration (HL goodness of fit testP= .1261) in the external validation sample.ConclusionThe START nomogram with good predictive performance is a reliable and simple clinical instrument to predict unfavorable outcome after acute stroke.